Study identifies 9 novel genes linked to gestational diabetes

The largest genetic study of gestational diabetes to date has led to a discovery of nine novel genetic regions linked to this severe and common pregnancy complication.

Neurocrine reports mixed results on schizophrenia therapy in mid-stage trial

Neurocrine Biosciences said Wednesday that the lowest dose of an experimental pill for schizophrenia reduced psychosis reported by patients in a mid-stage study, but higher

August 28, 2024

Psilocybin Treatment Helped Patients Process Emotions Related To Painful Past Events

Psilocybin, the active compound found in magic mushrooms, has shown promise in treating various addictions, as indicated by several previous studies. Case in point—a recent

June 15, 2023

AI is coming to your dentist’s office. Will it build trust, or erode it?

Open wide, AI wants a look inside your mouth. A new wave of software is promising to supercharge dentists’ ability to spot decay and bone

September 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.